Palisade bio receives fda fast track designation for lb1148 for reduction of adhesions following abdominal and pelvic surgery

Lb1148 was previously granted fast track designation from the u.s. food and drug administration (fda) for the treatment of postoperative gi dysfunction associated with pediatric cardiovascular surgery
PALI Ratings Summary
PALI Quant Ranking